Culturally congruent care and better understanding of the underlying causes are crucial to help achieve equitable treatment ...

Patient-centered care in MM involves aligning treatment with evolving quality-of-life priorities, especially during remission.

Saad Usmani, MD, Chief of MSK’s Myeloma Service, says the new combination therapy could be a “big step forward for people with extramedullary myeloma.” Researchers have made great progress in the ...

The latest data released at ASH 2025 offer new combination therapies for the treatment of multiple myeloma and new insights into the disease.

ORLANDO -- For triple-class exposed relapsed or refractory multiple myeloma with extramedullary disease (EMD), a combination of talquetamab (Talvey) and teclistamab (Tecvayli) achieved high response ...

Supportive care, including intravenous immunoglobulin, may improve outcomes by reducing infection risk in patients treated ...

-- Company to host a live webcast event with an expert panel of clinicians during ASH -- REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

The study evaluated the efficacy and safety of the investigational immunotherapy combination of TECVAYLI ® plus DARZALEX FASPRO ® versus DARZALEX FASPRO ® and dexamethasone with either pomalidomide or ...

TATIANA Schlossberg, the granddaughter of former US president John F. Kennedy, has died of cancer aged just 35. The news came ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...